Why the study?
Does heart failure treatment guided by BNP levels improve morbidity and mortality in extensively treated patients with chronic heart failure?
Does heart failure treatment guided by BNP levels improve morbidity and mortality in extensively treated patients with chronic heart failure?
BNP-guided treatment does not improve morbidity and mortality in extensively treated chronic heart failure patients, although patients who respond with lowered BNP have better outcomes.
Answers are grounded in this paper and cite their sources.
Does not support BNP-guided therapy in extensively treated chronic HF; confirms neutral primary result while extending focus to responders.
Morbidity and mortality were not improved by HF treatment guided by BNP levels. However, BNP responders had a significantly better clinical outcome than non-responders. Future research is needed to elucidate the responsible pathophysiological mechanisms in this sub-population.
No takes yet. Share an insight, caveat, or question.
Karlström et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: